Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 73 references it cites were found in a registry or an index, and 1 are not checked yet.

Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance

Open access

Abstract

As a metabolic center, the liver prevents inappropriate immune responses to abundant dietary antigens within the liver that could result in liver injury. This self-preservation mechanism can however decrease the efficiency of immunosurveillance of malignant cells by CD8 T cells. Hepatocellular carcinoma (HCC) is initiated by chronic viral infections, chronic alcohol consumption, and/or a fatty diet that leads to liver injury, fibrosis, and cirrhosis. HCC patients have high levels of dysfunctional and exhausted T cells, however, it is unclear which stage of HCC development contributes to T cell dysfunction. Repair of liver injury is initiated by interactions between injured hepatocytes and liver sinusoidal endothelial cells (LSEC), however, chronic injury can lead to fibrosis. Here, using a diethylnitrosamine/carbon tetrachloride (DEN/CCl 4) mouse model of early HCC development, we demonstrate that chronic liver injury and fibrosis are sufficient to induce a CD8 T cell exhaustion signature with a corresponding increase in expression of immunosuppressive molecules on LSEC. We show that LSEC alter T cell function at various stages of T cell differentiation/activation. LSEC compete with dendritic cells presenting the same antigen to naïve CD8 T cells resulting in a unique T cell phenotype. Furthermore, LSEC abrogate killing of target cells, in an antigen-dependent manner, by previously activated effector CD8 T cells, and LSEC change the effector cell cytokine profile. Moreover, LSEC induce functional T cell exhaustion under low dose chronic stimulation conditions. Thus, LSEC critically regulate the balance between preventing/limiting liver injury and permitting sufficient tumor immunosurveillance with normal hepatic functions likely contributing to HCC development under conditions of chronic liver insult.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2024.1497788

Cites

71 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The DEN/CCl4 mouse model induces liver injury, fibrosis, and early stages of HCC development. (A) C57BL/6 mice were injected at 14 days old with 25mg/kg DEN, and then beginning at 8 weeks of age, received twice weekly IP injections of 0.25μl/g CCl4 or of olive oil (control) for 8 weeks. (B) Mouse weights measured every 3-4 days for DEN/olive oil treated (red) or DEN/CCl4-treated (blue). Mice were sacrificed at ~16 weeks of age, and (C) the livers weighed, and then formalin-fixed for further histopathological analysis of (D) total liver injury, (E) liver cell injury, (F) inflammation, (G) reactive changes, and (H) steatosis as described in Materials and Methods. Representative images of (I) H&E staining (central vein (CV) and portal triad (PT), (J) Picrosirius Red staining, and (L) areas of hyperplasia/HCC, respectively. Summary graphs of (K) fibrosis and (M) areas of hyperplasia. Each dot denotes a mouse, ± SEM. *P ≤ 0.05, Student’s unpaired t test for B, C and Mann-Whitney test for D-H, K, M. n = 3 independent experiments, with 6-8 mice per experiment.
Figure 1 The DEN/CCl4 mouse model induces liver injury, fibrosis, and early stages of HCC development. (A) C57BL/6 mice were injected at 14 days old with 25mg/kg DEN, and then beginning at 8 weeks of age, received twice weekly IP injections of 0.25μl/g CCl4 or of olive oil (control) for 8 weeks. (B) Mouse weights measured every 3-4 days for DEN/olive oil treated (red) or DEN/CCl4-treated (blue). Mice were sacrificed at ~16 weeks of age, and (C) the livers weighed, and then formalin-fixed for further histopathological analysis of (D) total liver injury, (E) liver cell injury, (F) inflammation, (G) reactive changes, and (H) steatosis as described in Materials and Methods. Representative images of (I) H&E staining (central vein (CV) and portal triad (PT), (J) Picrosirius Red staining, and (L) areas of hyperplasia/HCC, respectively. Summary graphs of (K) fibrosis and (M) areas of hyperplasia. Each dot denotes a mouse, ± SEM. *P ≤ 0.05, Student’s unpaired t test for B, C and Mann-Whitney test for D-H, K, M. n = 3 independent experiments, with 6-8 mice per experiment.CC BY · PubMed Central
Figure 2 The DEN/CCl4 mouse model induces an exhausted phenotype in hepatic CD8 and CD4 T cells. On completion of DEN/CCl4 treatment, livers were harvested and digested, and NPC isolated and analyzed via flow cytometry. (A) Frequencies of hepatic CD3, CD4, and CD8 T cells in DEN/olive oil- (red) and DEN/CCl4-treated (blue) mice. (B) Representative flow cytometric plots of NPC gated on CD8+ T cells and analyzed for CD44, PD-1, TIGIT, and/or Tim3 frequencies. Panels (C, D) provide summary frequencies of CD44+, CD44+PD-1hi, PD-1hiTIGIT+, PD-1hi Tim3+, and TIGIT+Tim3+ for (C) CD8 and (D) CD4 T cells between DEN/olive oil- (red) and DEN/CCl4-treated (blue) mice with each dot denoting a mouse, ± SEM. *P ≤ 0.05, Student’s unpaired t test or Mann-Whitney test, n = 2 independent experiments, with 6-8 mice per experiment.
Figure 2 The DEN/CCl4 mouse model induces an exhausted phenotype in hepatic CD8 and CD4 T cells. On completion of DEN/CCl4 treatment, livers were harvested and digested, and NPC isolated and analyzed via flow cytometry. (A) Frequencies of hepatic CD3, CD4, and CD8 T cells in DEN/olive oil- (red) and DEN/CCl4-treated (blue) mice. (B) Representative flow cytometric plots of NPC gated on CD8+ T cells and analyzed for CD44, PD-1, TIGIT, and/or Tim3 frequencies. Panels (C, D) provide summary frequencies of CD44+, CD44+PD-1hi, PD-1hiTIGIT+, PD-1hi Tim3+, and TIGIT+Tim3+ for (C) CD8 and (D) CD4 T cells between DEN/olive oil- (red) and DEN/CCl4-treated (blue) mice with each dot denoting a mouse, ± SEM. *P ≤ 0.05, Student’s unpaired t test or Mann-Whitney test, n = 2 independent experiments, with 6-8 mice per experiment.CC BY · PubMed Central
Figure 3 Expression of immunosuppressive molecules are increased on LSEC by DEN/CCl4 treatment. NPC from DEN/olive oil- (red) or DEN/CCl4-treated (blue) mice were isolated as in Figure 2 and the expression of immunosuppressive molecules by LSEC (gated as CD45-CD146+CD31+PDPN-) determined by flow cytometric analysis. A representative histogram plot and a summary graph are shown for (A) PD-L1, (B) ICAM-1, (C) H2-Kb and (D) I-Ab expression on LSEC. Each dot denotes a mouse, values are normalized to the DEN/Olive oil average, ± SEM. *P ≤ 0.05, Student’s unpaired t test, n = 2 independent experiments, with 5-8 mice per experiment.
Figure 3 Expression of immunosuppressive molecules are increased on LSEC by DEN/CCl4 treatment. NPC from DEN/olive oil- (red) or DEN/CCl4-treated (blue) mice were isolated as in Figure 2 and the expression of immunosuppressive molecules by LSEC (gated as CD45-CD146+CD31+PDPN-) determined by flow cytometric analysis. A representative histogram plot and a summary graph are shown for (A) PD-L1, (B) ICAM-1, (C) H2-Kb and (D) I-Ab expression on LSEC. Each dot denotes a mouse, values are normalized to the DEN/Olive oil average, ± SEM. *P ≤ 0.05, Student’s unpaired t test, n = 2 independent experiments, with 5-8 mice per experiment.CC BY · PubMed Central
Figure 4 LSEC limit DC-mediated T cell activation. (A) Schematic of CTV-labeled naïve OT-I CD8 T cells cocultured in the presence of 2μg/ml N4 with primary splenic DC, primary LSEC, or splenic DC and LSEC. (B–D) After 72 hours of culture, the cells were harvested and analyzed via flow cytometry for (B) CD44, (C) PD-1, and (D) CD25 expression on OT-I CD8 T cells after culture with DC (red), LSEC (blue), or both DC and LSEC (green). A representative histogram (left) and a summary graph (right) are shown for each coculture condition, ± SEM. *P ≤ 0.05, Student’s paired t test or one sample t test (with theoretical value of 1), n = 5 independent experiments. E-G) After 72 hr of culture, supernatants were harvested and analyzed for the secretion of (E) IL-2, (F) IFNγ, and (G) TNF, ± SEM. *P ≤ 0.05, Student’s paired t test, n = 3-4. (H) After 72 hrs of culture, cells were harvested and analyzed for proliferation via CTV dilution using FlowJo software. A representative histogram and a summary graph displaying the proliferation index are shown, ± SEM. CTV staining for non-stimulated T cells is shown in turquoise. *P ≤ 0.05, Student’s paired t test, n = 3.
Figure 4 LSEC limit DC-mediated T cell activation. (A) Schematic of CTV-labeled naïve OT-I CD8 T cells cocultured in the presence of 2μg/ml N4 with primary splenic DC, primary LSEC, or splenic DC and LSEC. (B–D) After 72 hours of culture, the cells were harvested and analyzed via flow cytometry for (B) CD44, (C) PD-1, and (D) CD25 expression on OT-I CD8 T cells after culture with DC (red), LSEC (blue), or both DC and LSEC (green). A representative histogram (left) and a summary graph (right) are shown for each coculture condition, ± SEM. *P ≤ 0.05, Student’s paired t test or one sample t test (with theoretical value of 1), n = 5 independent experiments. E-G) After 72 hr of culture, supernatants were harvested and analyzed for the secretion of (E) IL-2, (F) IFNγ, and (G) TNF, ± SEM. *P ≤ 0.05, Student’s paired t test, n = 3-4. (H) After 72 hrs of culture, cells were harvested and analyzed for proliferation via CTV dilution using FlowJo software. A representative histogram and a summary graph displaying the proliferation index are shown, ± SEM. CTV staining for non-stimulated T cells is shown in turquoise. *P ≤ 0.05, Student’s paired t test, n = 3.CC BY · PubMed Central
Figure 5 LSEC potently inhibit CD8 effector T cell cytotoxicity while substantially increasing IFNγ production. (A) Schematic of cytotoxic assay depicting LSEC pulsed with either N4 or GP33 (control) peptides and cocultured with serially diluted OT-I effector CD8 T cells for 30 minutes prior to addition of target cells presenting either N4-specific peptide (N4-pulsed) or not (un-pulsed). Target cells (C57BL/6J splenocytes) were differentially labeled as CFSEhi or CFSElo, and CFSEhi cells were pulsed with N4, washed and combined with unpulsed CFSElo cells. After addition of the targets, the cocultures were maintained at 37C for 6 hr and then the cells were analyzed by flow cytometry. (B) Representative contour plots show the percent of N4-targets (CFSEhi) remaining of total CFSE+ cells at E:T ratios of 10:1 (left), 2.5:1 (middle), or 0.625:1 (right) for effector cells combined with target cells alone (top row), or together with N4-pulsed LSEC (middle row), or GP33-pulsed LSEC (bottom row). (C) Summary of OT-I CD8 T cell antigen-specific killing of target cells at decreasing E:T ratio shown as the ratio of N4-pulsed targets/unpulsed targets alone (purple dot) or in culture with effectors alone (red dots), effectors + N4-pulsed LSEC (blue dots), or effectors + GP33-pulsed LSEC (green dots), ± SEM. * denotes significant difference between targets cells cultured with effectors + N4-LSEC vs effectors alone or effectors + GP33-LSEC, P ≤ 0.05, Student’s paired t test, n = 4 independent experiments. (D) Culture supernatants were also analyzed for IFNγ production via ELISA after 6 hr of coculture and concentrations shown at different E:T ratios, ± SEM. * denotes significant difference between targets cells cultured with effectors + N4-LSEC (blue dots) vs effectors alone (red dots) or effectors + GP33-LSEC (green dots). Note: Overlap of some data points for effectors alone and effectors + GP33-LSEC obscure each other, however, all data points are contained in the graphs. P ≤ 0.05, Student’s paired t test, n = 3 independent experiments.
Figure 5 LSEC potently inhibit CD8 effector T cell cytotoxicity while substantially increasing IFNγ production. (A) Schematic of cytotoxic assay depicting LSEC pulsed with either N4 or GP33 (control) peptides and cocultured with serially diluted OT-I effector CD8 T cells for 30 minutes prior to addition of target cells presenting either N4-specific peptide (N4-pulsed) or not (un-pulsed). Target cells (C57BL/6J splenocytes) were differentially labeled as CFSEhi or CFSElo, and CFSEhi cells were pulsed with N4, washed and combined with unpulsed CFSElo cells. After addition of the targets, the cocultures were maintained at 37C for 6 hr and then the cells were analyzed by flow cytometry. (B) Representative contour plots show the percent of N4-targets (CFSEhi) remaining of total CFSE+ cells at E:T ratios of 10:1 (left), 2.5:1 (middle), or 0.625:1 (right) for effector cells combined with target cells alone (top row), or together with N4-pulsed LSEC (middle row), or GP33-pulsed LSEC (bottom row). (C) Summary of OT-I CD8 T cell antigen-specific killing of target cells at decreasing E:T ratio shown as the ratio of N4-pulsed targets/unpulsed targets alone (purple dot) or in culture with effectors alone (red dots), effectors + N4-pulsed LSEC (blue dots), or effectors + GP33-pulsed LSEC (green dots), ± SEM. * denotes significant difference between targets cells cultured with effectors + N4-LSEC vs effectors alone or effectors + GP33-LSEC, P ≤ 0.05, Student’s paired t test, n = 4 independent experiments. (D) Culture supernatants were also analyzed for IFNγ production via ELISA after 6 hr of coculture and concentrations shown at different E:T ratios, ± SEM. * denotes significant difference between targets cells cultured with effectors + N4-LSEC (blue dots) vs effectors alone (red dots) or effectors + GP33-LSEC (green dots). Note: Overlap of some data points for effectors alone and effectors + GP33-LSEC obscure each other, however, all data points are contained in the graphs. P ≤ 0.05, Student’s paired t test, n = 3 independent experiments.CC BY · PubMed Central
Figure 6 LSEC induce T cell exhaustion in CD8 T cells. (A) Schematic of in vitro culture for chronic vs acute antigen-specific stimulation of OT-I CD8 T cells. Primary LSEC and splenic DC were separately pulsed with 200nM N4 peptide for 30 min and washed. Naïve OT-I effector CD8 T cells were added to either N4-pulsed LSEC or N4-pulsed DC for 2 days. The cells were then resuspended and replated on day 2, 6, and 8 with IL-2 and either 2nM N4 (chronic stimulation) or no peptide (acute stimulation) and harvested on Day 9. (B) Representative phenotypic flow cytometric analysis of OT-I CD8+ T cells for PD-1 vs CD44, PD-1 vs Tim3, PD-1 vs TIGIT, and Tim3 vs TIGIT after LSEC chronic (left column) or acute (right) stimulation. (C) Summary graphs of each CD8 T cell phenotype after LSEC chronic (red dots) or acute (light red dots) stimulation and DC chronic (blue dots) or acute (light blue dots) stimulation. (D) Representative flow cytometric analysis of cytokine expression by OT-I CD8+ T cells after LSEC chronic (left column) or acute (right column) stimulation. IFNγ vs TNF (top), IL-2 vs IFNγ (middle) and IL-2 vs TNF (bottom). (E) Summary graphs of frequency of cytokine expression by OT-I CD8 T cells after LSEC chronic (red dots) or acute (light red dots) stimulation and DC chronic (blue dots) or acute (light blue dots) stimulation. Summary graphs comparing chronic and acute stimulations of OT-I CD8 T cells by either LSEC or DC are average frequencies, ± SEM. *P ≤ 0.05, Student’s paired t test, n = 5 independent experiments.
Figure 6 LSEC induce T cell exhaustion in CD8 T cells. (A) Schematic of in vitro culture for chronic vs acute antigen-specific stimulation of OT-I CD8 T cells. Primary LSEC and splenic DC were separately pulsed with 200nM N4 peptide for 30 min and washed. Naïve OT-I effector CD8 T cells were added to either N4-pulsed LSEC or N4-pulsed DC for 2 days. The cells were then resuspended and replated on day 2, 6, and 8 with IL-2 and either 2nM N4 (chronic stimulation) or no peptide (acute stimulation) and harvested on Day 9. (B) Representative phenotypic flow cytometric analysis of OT-I CD8+ T cells for PD-1 vs CD44, PD-1 vs Tim3, PD-1 vs TIGIT, and Tim3 vs TIGIT after LSEC chronic (left column) or acute (right) stimulation. (C) Summary graphs of each CD8 T cell phenotype after LSEC chronic (red dots) or acute (light red dots) stimulation and DC chronic (blue dots) or acute (light blue dots) stimulation. (D) Representative flow cytometric analysis of cytokine expression by OT-I CD8+ T cells after LSEC chronic (left column) or acute (right column) stimulation. IFNγ vs TNF (top), IL-2 vs IFNγ (middle) and IL-2 vs TNF (bottom). (E) Summary graphs of frequency of cytokine expression by OT-I CD8 T cells after LSEC chronic (red dots) or acute (light red dots) stimulation and DC chronic (blue dots) or acute (light blue dots) stimulation. Summary graphs comparing chronic and acute stimulations of OT-I CD8 T cells by either LSEC or DC are average frequencies, ± SEM. *P ≤ 0.05, Student’s paired t test, n = 5 independent experiments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Jepsen, 2007, Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends, Int J Cancer, 121, 10.1002/ijc.v121:7 · doi:10.1002/ijc.v121:7

Cited by

See all 19

Metadata

Authors
Kremer, K. N., Khammash, H. A., Miranda, A. M., Rutt, L. N., Twardy, S. M., Anton, P. E., Campbell, M. L., Garza-Ortiz, C., Orlicky, D. J., Pelanda, R., McCullough, R. L., & Torres, R. M.
Affiliations
University of Colorado Anschutz (US)
Corresponding author
  • Kremer, Kimberly N.
  • Torres, Raul M.
Venue
Frontiers in Immunology
Published
2025-01-17
Volume
15
Pages
1497788-1497788
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4406543123
Cited by
19
References
73
Citations by year
2026: 10 · 2025: 9
FWCI
10.68
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (AA029234 , AI143261, AA030741, ES032529, AI152535, AI156232, CA06934)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
liver sinusoidal endothelial cells, hepatocellular carcinoma, CD8+ T cell exhaustion, tumor surveillance, chronic liver injury, liver fibrosis, dendritic cells, T cell activation, T cell cytokine profile, liver injury repair
MeSH terms
Animals, Carbon Tetrachloride, Dendritic Cells, Diethylnitrosamine, Disease Models, Animal, Carcinoma, Hepatocellular, Immune Tolerance, Immunologic Surveillance, Liver, Liver Cirrhosis, Liver Neoplasms, Lymphocyte Activation, Male, Mice, Inbred C57BL, CD8-Positive T-Lymphocytes, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance. https://app.cochat.ai/papers/10.3389/fimmu.2024.1497788
The paper
Kremer, K. N., Khammash, H. A., Miranda, A. M., Rutt, L. N., Twardy, S. M., Anton, P. E., Campbell, M. L., Garza-Ortiz, C., Orlicky, D. J., Pelanda, R., McCullough, R. L., & Torres, R. M. (2025). Liver sinusoidal endothelial cells regulate the balance between hepatic immunosuppression and immunosurveillance. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1497788

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.